SEC Info℠

Home

Search

My Interests

Help

Sign In

Please Sign In

Cocoluv Inc. – ‘10-Q’ for 2/29/20

On:  Tuesday, 4/14/20, at 11:17am ET   ·   For:  2/29/20   ·   Accession #:  1477932-20-1917   ·   File #:  333-227066

Previous ‘10-Q’:  ‘10-Q’ on 1/15/20 for 11/30/19   ·   Next:  ‘10-Q’ on 10/9/20 for 8/31/20   ·   Latest:  ‘10-Q’ on 4/22/24 for 2/29/24

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

 Text Wildcards:  ? (any letter/digit),  * (many).  Search Logic:  for Documents:  & (and),  | (or);  for Text:  | (anywhere),  "(&)" (near).  Details... 

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/14/20  Cocoluv Inc.                      10-Q        2/29/20   29:916K                                   Discount Edgar/FA

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    152K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     16K 
 3: EX-32.1     Certification -- §906 - SOA'02                      HTML     12K 
19: R1          Document and Entity Information                     HTML     54K 
27: R2          Balance Sheets                                      HTML     48K 
25: R3          Balance Sheets (Parenthetical)                      HTML     21K 
11: R4          Statements of Operations (Unaudited)                HTML     34K 
18: R5          Statement of Stockholders Deficit                   HTML     32K 
26: R6          Statement of Cash Flows (Unaudited)                 HTML     51K 
24: R7          Nature of Operations and Basis of Presentation      HTML     17K 
10: R8          Summary of Significant Accounting Policies          HTML     23K 
20: R9          Common Stock                                        HTML     16K 
22: R10         Related Party Transactions                          HTML     15K 
29: R11         Subsequent Events                                   HTML     14K 
17: R12         Summary of Significant Accounting Policies          HTML     52K 
                (Policies)                                                       
15: R13         Nature of Operations and Basis of Presentation      HTML     34K 
                (Details Narrative)                                              
21: R14         Summary of Significant Accounting Policies          HTML     15K 
                (Details Narrative)                                              
28: R15         Common Stock (Details Narrative)                    HTML     32K 
16: R16         Related Party Transactions (Details Narrative)      HTML     31K 
14: R17         Subsequent Events (Details Narrative)               HTML     24K 
13: XML         IDEA XML File -- Filing Summary                      XML     44K 
12: EXCEL       IDEA Workbook of Financial Reports                  XLSX     23K 
 4: EX-101.INS  XBRL Instance -- coco-20200229                       XML    253K 
 7: EX-101.CAL  XBRL Calculations -- coco-20200229_cal               XML     26K 
 9: EX-101.DEF  XBRL Definitions -- coco-20200229_def                XML    103K 
 6: EX-101.LAB  XBRL Labels -- coco-20200229_lab                     XML    233K 
 8: EX-101.PRE  XBRL Presentations -- coco-20200229_pre              XML    206K 
 5: EX-101.SCH  XBRL Schema -- coco-20200229                         XSD     46K 
23: ZIP         XBRL Zipped Folder -- 0001477932-20-001917-xbrl      Zip     33K 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 29, 2020

Commission File Number 333-227066

1390 Main Street, Suite 20, San Francisco, CA., 97204

(Address of principal executive offices) (Zip Code)

800-294-8513

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes   ☒ No

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☐ Yes   ☒ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☒ Yes   ☐ No

As of April 14, 2020, there were 4,000,000 shares of common stock issued and outstanding.

TABLE OF CONTENTS

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

COCOLUV INC.

FINANCIAL STATEMENTS

February 29, 2020

(unaudited)

COCOLUV INC.

BALANCE SHEETS

The accompanying notes are an integral part of these financial statements.

COCOLUV INC.

STATEMENTS OF OPERATIONS

(unaudited)

The accompanying notes are an integral part of these financial statements. 

COCOLUV INC.

STATEMENT OF STOCKHOLDERS’ DEFICIT

FOR THE NINE-MONTH PERIOD FROM JUNE 1, 2019 TO FEBRUARY 29, 2020

STATEMENT OF STOCKHOLDERS’ DEFICIT

FOR THE NINE-MONTHPERIOD FROM JUNE 1, 2018 TO FEBRUARY 28, 2019

The accompanying notes are an integral part of these financial statements.

COCOLUV INC.

STATEMENT OF CASH FLOWS

(unaudited)

The accompanying notes are an integral part of these financial statements.

COCOLUV INC.

NOTES TO FINANCIAL STATEMENTS 

NOTE 1 – NATURE OF OPERATIONS AND BASIS OF PRESENTATION

CocoLuv Inc. was incorporated in the State of Nevada as a for-profit Company on September 13, 2017 and established a fiscal year end of May 31.  The Company intends to manufacture market and sell a product line of 5 hair care products derived from Virgin Coconut Oil. The initial 5 products will be 3 for women and 2 for men.

Going concern

To date the Company has generated no revenues from its business operations and has incurred operating losses since inception of $46,046.  As at February 29, 2020, the Company has a working capital deficit of $30,646.  The Company will require additional funding to meet its ongoing obligations and to fund anticipated operating losses.  The ability of the Company to continue as a going concern is dependent on raising capital to fund its initial business plan and ultimately to attain profitable operations.  Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern.  The Company intends to continue to fund its business by way of private placements and advances from related parties as may be required. As of February 29, 2020, the Company has issued 4,000,000 founders shares at $0.001 per share for net proceeds of $4,000 to the Company and Private Placements of 228,000 common shares at $0.05 per share for net proceeds of $11,400. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for financial information and with the instructions to Form 10-Q.  They do not include all information and footnotes required by United States generally accepted accounting principles for complete financial statements.  However, except as disclosed herein, there has been no material changes in the information disclosed in the notes to the financial statements for the fiscal year ended May 31, 2019 included in the Company’s year-end financial statements on Form 10-K filed with the Securities and Exchange Commission.  The unaudited financial statements should be read in conjunction with those financial statements included in the Form 10-K. In the opinion of Management, all adjustments considered necessary for a fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the nine-months ended February 29, 2020 are not necessarily indicative of the results that may be expected for the year ending May 31, 2020.

Use of Estimates and Assumptions

Preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period.  Accordingly, actual results could differ from those estimates.

Commitments and Contingencies

On September 26, 2018 the Company signed a lease for office space in San Francisco, California. The term of the lease is for one year at $54 per month. The term of the lease is for automatically renewed annually at $68 per month.

Cash and Cash Equivalents

For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents.

Fair Value of Financial Instruments

The carrying amount of the Company’s financial assets and liabilities approximates their fair values due to their short-term maturities.

COCOLUV INC.

NOTES TO FINANCIAL STATEMENTS 

Loss per Common Share

The basic loss per share is calculated by dividing the Company’s net loss available to common shareholders by the weighted average number of common shares during the year. The diluted loss per share is calculated by dividing the Company’s net loss available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Diluted loss per share is the same as basic loss per share due to the lack of dilutive items in the Company. As of February 29, 2020, there were no common stock equivalents outstanding.

Income Taxes

The Company follows the liability method of accounting for income taxes.  Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax balances and tax loss carry-forwards.  Deferred tax assets and liabilities are measured using enacted or substantially enacted tax rates expected to apply to the taxable income in the years in which those differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment or substantive enactment. 

Stock-based Compensation

The Company follows ASC 718-10, "Stock Compensation", which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 is a revision to SFAS No. 123, "Accounting for Stock-Based Compensation," and supersedes Accounting Principles Board ("APB") Opinion No. 25, "Accounting for Stock Issued to Employees," and its related implementation guidance. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized. The Company has not adopted a stock option plan and has not granted any stock options. As at February 29, 2020 the Company had not adopted a stock option plan nor had it granted any stock options.  Accordingly, no stock-based compensation has been recorded to date.

Recent Accounting Pronouncements

The Company does not expect the adoption of any recent accounting pronouncements to have a material impact on its financial statements.

NOTE 3 – COMMON STOCK

The Company’s capitalization is 200,000,000 common shares with a par value of $0.001 per share.  No preferred shares have been authorized or issued.

On September 30, 2017, the Company issued 4,000,000 common shares at $0.001 per share to the sole director and President of the Company. The Company received net proceeds of $4,000 in payment of the shares.

Between August, 2019 and February, 2020 the Company sold 228,000 shares of its common stock at $0.05 for $11,400 net proceeds to the Company. As of February 29, 2020 the Company had not issued these shares.  This is reflected on the balance sheet as shares to be issued.

During the subsequent period, on March 3, 2020 the Company sold 60,000 shares of its common stock at $0.05 for $3,000 net proceeds to the Company. As of the filing of this report the Company had not issued these shares. 

As of February 29, 2020, 4,000,000 common shares issued and outstanding. 

COCOLUV INC.

NOTES TO FINANCIAL STATEMENTS

NOTE 4 – RELATED PARTY TRANSACTIONS

During the nine-month period ended February 29, 2020, the Company received cash advances from its CEO of $20. Additionally, the CEO paid expenses of $16,055 on behalf of the Company. Total amount owed to the CEO as of February 29, 2020 is $24,428. The amounts due to related party are unsecured and non- interest-bearing with no set terms of repayment.

On September 30, 2017, the Company issued 4,000,000 common shares at $0.001 per share to the sole director and President of the Company. The Company received net proceeds of $4,000 in payment of the shares.

NOTE 5 – SUBSEQUENT EVENTS

During the subsequent period, on March 3, 2020 the Company sold 60,000 shares of its common stock at $0.05 for $3,000 net proceeds to the Company. As of the filing of this report the Company had not issued these shares. 

During the subsequent period, on March, 2020, the Company received cash advances from its CEO of $2,530.  The amounts due to related party are unsecured and non- interest-bearing with no set terms of repayment.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This section of this Form 10-Q includes a number of forward-looking statements that reflect our current views with respect to future events and financial performance. Forward-looking statements are often identified by words like believe, expect, estimate, anticipate, intend, project and similar expressions, or words which, by their nature, refer to future events. You should not place undue certainty on these forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our predictions.

Business Overview

CocoLuv Inc. (“CocoLuv Inc.” or the “Company”) was incorporated in the State of Nevada. We are an early stage company that plans to commence operations as an online retailer offering was incorporated in the State of Nevada as a for-profit Company on September 13, 2017 and established a fiscal year end of May 31. The Company intends to manufacture market and sell a product line of 5 hair care products derived from Virgin Coconut Oil. The initial 5 products will be 3 for women and 2 for men.

CocoLuv Inc. is an emerging growth stage company which intends to manufacture market and sell a proposed product line of 5 hair care products derived from Virgin Coconut Oil. We currently have no product to sell, but we intend to create a haircare line of that will initially consist of 5 products; 3 for women and 2 for men. Our proposed products will be of superior quality in that they will have a base of Virgin Coconut Oil. CocoLuv Inc. CocoLuv Inc. anticipates that it will derive its income from the sale of its intended products as follows: Hair Shine (for women), Curl Balm (for women), Hair Treatment (for women), Hair Pomade (for men’s hair, beards, moustaches) and Hair Cream (for men). We do not anticipate revenues until such time as we enter into retail operations. Since we are presently in the development stage of our business, we can provide no assurance that we will successfully bring retail online sales to fruition.

We have not earned any revenues to date. Our independent registered public accountant has issued an audit opinion which includes a statement expressing substantial doubt as to our ability to continue as a going concern.

Results of Operations Three and Nine-month periods

For the three-month periods ended February 29, 2020 and February 28, 2019, we had no revenue. Expenses for the three-month period ended February 29, 2020 totaled $15,711 resulting in a net loss of $15,711, compared to expenses for the three-month period ended February 28, 2019, totaled $2,943 resulting in a net loss of $2,943. The net loss for the three-month period ended February 29, 2020 is a result of office and general expense of $15,711 comprised primarily of professional fees of $14,900; filing fees of $500; telephone expenses of $27; rent expenses of $231; and bank service charges of $53. Compared to expenses for the three-months ended February 28, 2019 is a result of office and general expenses of $2,943 comprised primarily of professional fees of $2,500; filing fees of $202; telephone expenses of $18; rent expense of $190; and bank service charges of $33. The increase in expenses for the three-month period ended February 29, 2020 compared to February 28, 2019 is primarily due to an increase in professional fees, which is consulting increasing $11,000 during the period.

For the nine-month periods ended February 29, 2020 and February 28, 2019, we had no revenue. Expenses for the nine-month period ended February 29, 2020 totaled $29,045 resulting in a net loss of $29,045, compared to expenses for the nine-month period ended February 28, 2019, totaled $11,031 resulting in a net loss of $11,031. The net loss for the nine-month period ended February 29, 2020 is a result of office and general expense of $29,045 comprised primarily of professional fees of $25,100; filing fees of $2,903; telephone expenses of $82; rent expenses of $668; and bank service charges of $292. Compared to expenses for the nine-months ended February 28, 2019 is a result of office and general expenses of $11,031 comprised primarily of professional fees of $9,200; filing fees of $1,166; telephone expenses of $84; rent expense of $484; and bank service charges of $97. The increase in expenses for the nine-month period ended February 29, 2020 compared to February 28, 2019 is primarily due to an increase in professional fees, which is consulting fee increase $11,000 and legal and accounting fee increase $7,100 during the period. 

Capital Resources and Liquidity

There is substantial doubt that we can continue as an on-going business for the next twelve months unless we obtain additional capital. No substantial revenues are anticipated until we have implemented our plan of operations. With the exception of cash advances from our sole Officer and Director, our only source for cash at this time is investments by others by way of private placements. Since inception, we have raised $7,900 through the sale of Company’s common stock. We must raise additional cash to implement our strategy and stay in business.

On September 30, 2017, the Company issued 4,000,000 common shares at $0.001 per share to the sole director and President of the Company. The Company received net proceeds of $4,000 in payment of the shares.

Between August 19, 2019 to February 2020, the Company sold 228,000 shares of its common stock at $0.05 for $11,400 net proceeds to the Company. As of February 29, 2020 the Company had not issued these shares. This is reflected on the balance sheet as shares to be issued.

During the subsequent period, on March 3, 2020 the Company sold 60,000 shares of its common stock at $0.05 for $3,000 net proceeds to the Company. As of the filing of this report the Company had not issued these shares. During the subsequent period, on March, 2020, the Company received cash advances from its CEO of $2,530. The amounts due to related party are unsecured and non- interest-bearing with no set terms of repayment.

As of February 29, 2020, we had $332 in cash as compared to $54 in cash at May 31, 2019. The funds available to the Company will not be sufficient to fund the planned operations of the Company and maintain a reporting status. As of February 29, 2020, the Company’s officer and director Mr. Guillermo has loaned the Company $24,428 and Mr. Guillermo has indicated that he may be willing to provide a maximum of $60,000, required to maintain the reporting status, in the form of a non-secured loan for the next twelve months as the expenses are incurred if no other proceeds are obtained by the Company. However, there is no contract or written agreement in place.

We anticipate that we will begin the development of our proposed business plan to purchase overstocked inventory items and offer them to the public via a web-based on-line store and hire additional consultants to setup out website within the next 24 month period.

Off-balance sheet arrangements

Other than the situation described in the section titled Capital Recourses and Liquidity, the company has no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect or change on the company’s financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors. The term “off-balance sheet arrangement” generally means any transaction, agreement or other contractual arrangement to which an entity unconsolidated with the company is a party, under which the company has (i) any obligation arising under a guarantee contract, derivative instrument or variable interest; or (ii) a retained or contingent interest in assets transferred to such entity or similar arrangement that serves as credit, liquidity or market risk support for such assets

Critical Accounting Policies and Estimates

The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Risks

As a “smaller reporting company,” as defined in Rule 12b-2 of the Exchange Act, we are not required to provide the information called for by this Item.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time period specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is accumulated and communicated to management including our principal executive officer and principal financial officer as appropriate, to allow timely decisions regarding required disclosure.

In connection with this quarterly report, as required by Rule 15d-15 under the Securities Exchange Act of 1934, we have carried out an evaluation of the effectiveness of the design and operation of our company's disclosure controls and procedures. The material weaknesses in our disclosure control procedures are as follows:

1. Lack of formal policies and procedures necessary to adequately review significant accounting transactions. We utilize a third-party independent contractor for the preparation of our financial statements. Although the financial statements and footnotes are reviewed by our management, we do not have a formal policy to review significant accounting transactions and the accounting treatment of such transactions. The third-party independent contractor is not involved in our day to day operations and may not be provided information from our management on a timely basis to allow for adequate reporting/consideration of certain transactions.

2. Lack of audit committee and financial expert. We do not have an audit committee with a financial expert and, thus, we lack the appropriate oversight within the financial reporting process.

We intend to initiate measures to remediate the identified material weaknesses, including, but not necessarily limited to, the following:

Changes in Internal Control Over Financial Reporting

None 

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

Currently, we are not involved in any pending litigation or legal proceeding.

Item 1A. Risk Factors.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

Item 2. Unregistered Sales of Securities and Use of Proceeds.

None

Item 3. Defaults Upon Senior Securities.

None

Item 4. Mine Safety Disclosures

None

Item 5. Other Information.

None

Item 6. Exhibits.

_________ 

* Included in Exhibit 31.1

** Included in Exhibit 32.1 

SIGNATURES*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

---

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing		Date		Other Filings
		5/31/20
Filed on:		4/14/20
		3/3/20
For Period end:		2/29/20
		11/30/19		10-Q,  NT 10-Q
		8/31/19		10-Q
		8/19/19
		6/1/19
		5/31/19		10-K
		2/28/19		10-Q
		11/30/18
		9/26/18		S-1/A
		8/31/18
		6/1/18
		5/31/18
		9/30/17
		9/13/17
				List all Filings

↑Top

---

Filing Submission 0001477932-20-001917   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

---

---

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., Apr. 25, 9:41:52.1am ET